Loading…
The Ayush Quality Mark, launched 19 December 2025 at the 2nd WHO Global Summit on Traditional Medicine, is a unified quality-assurance framework covering Ayush products, hospitals, day-care centres, wellness centres, testing labs and Medical Value Travel Facilitators.
Implementation has been entrusted to AYUSHEXCIL, the DGFT-notified Ayush Export Promotion Council under the Ministry of Commerce, supported by the Ministry of Ayush.
The AOGUSY scheme (₹122 crore over five years, approved 2021) backs quality infrastructure — 34 State and 118 approved private Drug Testing Laboratories now test Ayush drug quality nationally.
Strengthen Ayush quality-control infrastructure, regulatory capacity and pharmacovigilance
Key: SFC-approved 16 March 2021; ₹122 crore over 5 years; funded 3 State DTL upgrades in FY2025-26 (₹17.50 crore grant-in-aid allocation)
Third-party certification of Ayush drug quality
Key: Awarded by the Quality Council of India (QCI) based on compliance with national and international quality standards
DGFT-notified Ayush Export Promotion Council implementing the Ayush Quality Mark
Sets pharmacopoeial standards for Ayush drugs; also functions as the Appellate Drug Testing Laboratory for Ayush drugs
Issues the WHO Certificate of Pharmaceutical Product (CoPP) for exported Ayush drugs, jointly with the Ministry of Ayush and State Licensing Authorities
Exclusive regulatory provisions (Schedule T, Schedule M-I) govern licensing, GMP compliance and quality standards for Ayurveda, Siddha, Sowa-Rigpa, Unani and Homoeopathy drugs
GS Paper 3 > External Trade > Export Promotion & Quality Regulation
In the context of India, which one of the following is the characteristic appropriate for bureaucracy?
Answer: An agency for the implementation of public policy
New initiative (December 2025); likely to recur as implementation expands
Ayush Export Promotion Council, notified by DGFT under the Ministry of Commerce and supported by the Ministry of Ayush, tasked with implementing the Ayush Quality Mark.
Certificate of Pharmaceutical Product — a WHO-format certificate issued by CDSCO for exported Ayush drugs, used for product registration in importing countries.